135 related articles for article (PubMed ID: 1662636)
1. Azithromycin versus cefaclor in the treatment of acute bacterial pneumonia.
Kinasewitz G; Wood RG
Eur J Clin Microbiol Infect Dis; 1991 Oct; 10(10):872-7. PubMed ID: 1662636
[TBL] [Abstract][Full Text] [Related]
2. Multicenter evaluation of azithromycin and cefaclor in acute lower respiratory tract infections.
Dark D
Am J Med; 1991 Sep; 91(3A):31S-35S. PubMed ID: 1656740
[TBL] [Abstract][Full Text] [Related]
3. Double-blind, double-dummy comparison of azithromycin and cephalexin in the treatment of skin and skin structure infections.
Kiani R
Eur J Clin Microbiol Infect Dis; 1991 Oct; 10(10):880-4. PubMed ID: 1662638
[TBL] [Abstract][Full Text] [Related]
4. Clinical efficacy of azithromycin in lower respiratory tract infections.
Morandini G; Perduca M; Zannini G; Foschino MP; Miragliotta G; Carnimeo NS
J Chemother; 1993 Feb; 5(1):32-6. PubMed ID: 8384658
[TBL] [Abstract][Full Text] [Related]
5. Clinical and bacteriological outcomes in hospitalised patients with community-acquired pneumonia treated with azithromycin plus ceftriaxone, or ceftriaxone plus clarithromycin or erythromycin: a prospective, randomised, multicentre study.
Tamm M; Todisco T; Feldman C; Garbino J; Blasi F; Hogan P; de Caprariis PJ; Hoepelman IM
Clin Microbiol Infect; 2007 Feb; 13(2):162-171. PubMed ID: 17328728
[TBL] [Abstract][Full Text] [Related]
6. Comparison of azithromycin versus clarithromycin in the treatment of patients with lower respiratory tract infection.
Bradbury F
J Antimicrob Chemother; 1993 Jun; 31 Suppl E():153-62. PubMed ID: 8396087
[TBL] [Abstract][Full Text] [Related]
7. A comparative study of the efficacy, safety and tolerability of azithromycin and cefaclor in the treatment of children with acute skin and/or soft tissue infections.
Montero L
J Antimicrob Chemother; 1996 Jun; 37 Suppl C():125-31. PubMed ID: 8818853
[TBL] [Abstract][Full Text] [Related]
8. Simplified treatment of acute lower respiratory tract infection with azithromycin: a comparison with erythromycin and amoxycillin. European Azithromycin Study Group.
Daniel R
J Int Med Res; 1991; 19(5):373-83. PubMed ID: 1660824
[TBL] [Abstract][Full Text] [Related]
9. [Clinical evaluation of BMY-28100 for bacterial pneumonia in comparison with cefaclor in a double-blind study].
Oizumi K; Watanabe A; Saito A; Tomizawa M; Nakayama I; Hiraga Y; Ohmichi M; Tamura M; Konishi K; Gomi K
Jpn J Antibiot; 1990 Nov; 43(11):1914-47. PubMed ID: 2287058
[TBL] [Abstract][Full Text] [Related]
10. Clarithromycin versus cefaclor for the treatment of mild-to-moderate acute bacterial bronchitis.
Wettengel R; Vetter N; Waardenburg FA
J Antimicrob Chemother; 1993 Jun; 31(6):963-72. PubMed ID: 8360133
[TBL] [Abstract][Full Text] [Related]
11. An open study to compare azithromycin with cefaclor in the treatment of children with acute otitis media.
Rodriguez AF
J Antimicrob Chemother; 1996 Jun; 37 Suppl C():63-9. PubMed ID: 8818847
[TBL] [Abstract][Full Text] [Related]
12. Comparison of azithromycin versus clarithromycin in the treatment of patients with upper respiratory tract infections.
Müller O
J Antimicrob Chemother; 1993 Jun; 31 Suppl E():137-46. PubMed ID: 8396085
[TBL] [Abstract][Full Text] [Related]
13. An open comparative study of azithromycin versus cefaclor in the treatment of patients with upper respiratory tract infections.
O'Doherty B
J Antimicrob Chemother; 1996 Jun; 37 Suppl C():71-81. PubMed ID: 8818848
[TBL] [Abstract][Full Text] [Related]
14. Loracarbef (LY163892) versus cefaclor in the treatment of bacterial skin and skin-structure infections in an adult population.
McCarty J; Ruoff GE; Jacobson KD
Am J Med; 1992 Jun; 92(6A):80S-85S. PubMed ID: 1621751
[TBL] [Abstract][Full Text] [Related]
15. [A double blind comparative study on the efficacy of S6472, cefaclor and amoxicillin, in the treatment of bacterial pneumonia].
Shibaki H; Chimoto T; Nakabayashi T; Ishii Y; Tosaka M; Watanabe H; Onodera S; Shimizu T; Sasaki N; Ikeda Y
Jpn J Antibiot; 1986 Mar; 39(3):853-86. PubMed ID: 3525883
[TBL] [Abstract][Full Text] [Related]
16. The efficacy and tolerance of a three-day course of azithromycin in the treatment of community-acquired pneumonia.
Myburgh J; Nagel GJ; Petschel E
J Antimicrob Chemother; 1993 Jun; 31 Suppl E():163-9. PubMed ID: 8396088
[TBL] [Abstract][Full Text] [Related]
17. [A double-blind comparative study of S 6472 (a long-acting cefaclor) versus a conventional cefaclor preparation in complicated urinary tract infections].
Arakawa S; Takagi S; Matsumoto O; Kamidono S; Hirooka K; Hamami G; Matsumoto H; Saito H; Umezu K; Ishigami J
Jpn J Antibiot; 1990 Nov; 43(11):1873-92. PubMed ID: 2287055
[TBL] [Abstract][Full Text] [Related]
18. Clinical comparative study of azithromycin versus erythromycin in the treatment of acute respiratory tract infections in children.
Manfredi R; Jannuzzi C; Mantero E; Longo L; Schiavone R; Tempesta A; Pavesio D; Pecco P; Chiodo F
J Chemother; 1992 Dec; 4(6):364-70. PubMed ID: 1337553
[TBL] [Abstract][Full Text] [Related]
19. Comparison of the efficacy and safety of ceftibuten and cefaclor in the treatment of pneumonia and bronchiectasis.
McCabe R; Rumans L; Perrotta R; Mogabgab W
J Chemother; 1993 Apr; 5(2):124-32. PubMed ID: 8515295
[TBL] [Abstract][Full Text] [Related]
20. Loracarbef (LY163892) versus cefaclor in the treatment of acute bacterial bronchitis.
Dere WH; Farlow D; Therasse DG; Ruoff GE
Clin Ther; 1992; 14(1):41-53. PubMed ID: 1576625
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
